Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1

被引:108
作者
Zhang, LQ
He, T
Huang, YX
Chen, ZW
Guo, Y
Wu, S
Kunstman, KJ
Brown, RC
Phair, JP
Neumann, AU
Ho, DD
Wolinsky, SM
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[3] Bar Ilan Univ, Dept Life Sci, IL-52900 Ramat Gan, Israel
关键词
D O I
10.1128/JVI.72.11.9307-9312.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We tested chemokine receptor subset usage by diverse, well-characterized primary viruses isolated from peripheral blood by monitoring viral replication with CCR1, CCR2b, CCR3, CCR5, and CXCR4 U87MG.CD4 transformed cell lines and STRL33/BONZO/TYMSTR and GPR15/BOB HOS.CD4 transformed cell lines. primary viruses were isolated from 79 men with confirmed human immunodeficiency virus type 1 (HIV-1) infection from the Chicago component of the Multicenter AIDS Cohort Study at interval time points. Thirty-five additional well-characterized primary viruses representing HIV-1 group M subtypes A, B, C, D, and E and group O and three primary simian immunodeficiency virus (SIV) isolates were also used for these studies. The restricted use of the CCR5 chemokine receptor for viral entry was associated with infection by a virus having a non-syncytium-inducing phenotype and correlated with a reduced rate of disease progression and a prolonged disease-free interval. Conversely, broadening chemokine receptor usage from CCR5 to both CCR5 and CXCR4 was associated with infection by a virus having a syncytium-inducing phenotype and correlated with a faster rate of CD4 T-cell decline and progression of disease. We also observed a greater tendency for infection with a virus having a syncytium-inducing phenotype in men heterozygous for the defective CCR5 Delta 32 allele (25%) than in those men homozygous for the wild-type CCR5 allele (6%) (P = 0.03), The propensity for infection with a virus having a syncytium-inducing phenotype provides a partial explanation for the rapid disease progression among some men heterozygous for the defective CCR5 Delta 32 allele, Furthermore, we did not identify any primary viruses that used CCR3 as an entry cofactor, despite this CC chemokine receptor being expressed on the cell surface at a level commensurate with or higher than that observed for primary peripheral blood mononuclear cells. Whereas isolates of primary viruses of SIV also used STRL33/BONZO/TYMSTR and GPR15/BOB, no primary isolates of HN-P used these particular chemokine receptor-like orphan molecules as entry cofactors, suggesting a limited contribution of these other chemokine receptors to viral evolution, Thus, despite the number of chemokine receptors implicated in viral entry, CCR5 and CXCR4 are likely to be the physiologically relevant chemokine receptors used as entry cofactors in vivo by diverse strains of primary viruses isolated from blood.
引用
收藏
页码:9307 / 9312
页数:6
相关论文
共 54 条
[21]   A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors [J].
Doranz, BJ ;
Rucker, J ;
Yi, YJ ;
Smyth, RJ ;
Samson, M ;
Peiper, SC ;
Parmentier, M ;
Collman, RG ;
Doms, RW .
CELL, 1996, 85 (07) :1149-1158
[22]   HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].
Dragic, T ;
Litwin, V ;
Allaway, GP ;
Martin, SR ;
Huang, YX ;
Nagashima, KA ;
Cayanan, C ;
Maddon, PJ ;
Koup, RA ;
Moore, JP ;
Paxton, WA .
NATURE, 1996, 381 (6584) :667-673
[23]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[24]   The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection [J].
Frade, JMR ;
Llorente, M ;
Mellado, M ;
Alcami, J ;
GutierrezRamos, JC ;
Zaballos, A ;
delReal, G ;
MartinezA, C .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :497-502
[25]   GENETIC-VARIATION OF HIV TYPE-1 IN 4 WORLD-HEALTH-ORGANIZATION-SPONSORED VACCINE EVALUATION SITES - GENERATION OF FUNCTIONAL ENVELOPE (GLYCOPROTEIN-160) CLONES REPRESENTATIVE OF SEQUENCE SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E [J].
GAO, F ;
YUE, L ;
CRAIG, S ;
THORNTON, CL ;
ROBERTSON, DL ;
MCCUTCHAN, FE ;
BRADAC, JA ;
SHARP, PM ;
HAHN, BH ;
OSMANOV, S ;
BELSEY, EM ;
HEYWARD, W ;
ESPARZA, J ;
GALVAOCASTRO, B ;
VANDEPERRE, P ;
KARITA, E ;
WASI, C ;
SEMPALA, S ;
TUGUME, B ;
BIRYAHWAHO, B ;
RUBSAMENWAIGMANN, H ;
VONBRIESEN, H ;
ESSER, R ;
GREZ, M ;
HOLMES, H ;
NEWBERRY, A ;
RANJBAR, S ;
TOMLINSON, P ;
BRADAC, J ;
MCCUTCHAN, F ;
LOUWAGIE, J ;
HEGERICH, P ;
LOPEZGALINDEZ, C ;
OLIVARES, I ;
DOPAZO, J ;
MULLINS, JI ;
DELWART, EL ;
BACHMANN, HM ;
GOUDSMIT, J ;
DEWOLF, F ;
SARAGOSTI, S ;
SCHOCHETMAN, G ;
KALISH, M ;
LUO, CC ;
GEORGE, R ;
PAU, CP ;
WEBER, J ;
CHEINGSONGPOPOV, R ;
KALEEBU, P ;
NARA, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1359-1368
[26]   Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G [J].
Gao, F ;
Morrison, SG ;
Robertson, DL ;
Thornton, CL ;
Craig, S ;
Karlsson, G ;
Sodroski, J ;
Morgado, M ;
GalvaoCastro, B ;
vonBriesen, H ;
Beddows, S ;
Weber, J ;
Sharp, PM ;
Shaw, GM ;
Hahn, BH ;
Osmanov, S ;
Heyward, WL ;
Esparza, J ;
vandePerre, P ;
Karita, E ;
Sempala, S ;
Tugume, B ;
Biryahwaho, B ;
Wasi, C ;
RubsamenWaigmann, H ;
Holmes, H ;
Newberry, A ;
Ranjbar, S ;
Tomlinson, P ;
Bradac, J ;
Mullins, JI ;
Delwart, EL ;
CheingsongPopov, R ;
Kaleebu, P ;
Myers, G ;
Korber, BTM ;
Chiphangwi, J ;
Taha, T ;
Desormeaux, J ;
Eiumtrakul, S ;
Natpratan, C ;
Khamboonruang, C ;
Miotti, P ;
Halsey, NA ;
Vlahov, D ;
Nelson, KE ;
Phair, J ;
Cao, Y ;
Moore, JP ;
Ho, DD .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1651-1667
[27]   CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia [J].
He, JL ;
Chen, YZ ;
Farzan, M ;
Choe, HY ;
Ohagen, A ;
Gartner, S ;
Busciglio, J ;
Yang, XY ;
Hofmann, W ;
Newman, W ;
Mackay, CR ;
Sodroski, J ;
Gabuzda, D .
NATURE, 1997, 385 (6617) :645-649
[28]   QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS [J].
HO, DD ;
MOUDGIL, T ;
ALAM, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1621-1625
[29]   The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [J].
Huang, YX ;
Paxton, WA ;
Wolinsky, SM ;
Neumann, AU ;
Zhang, LQ ;
He, T ;
Kang, S ;
Ceradini, D ;
Jin, ZQ ;
Yazdanbakhsh, K ;
Kunstman, K ;
Erickson, D ;
Dragon, E ;
Landau, NR ;
Phair, J ;
Ho, DD ;
Koup, RA .
NATURE MEDICINE, 1996, 2 (11) :1240-1243
[30]   LYMPHOCYTE-T T4 MOLECULE BEHAVES AS THE RECEPTOR FOR HUMAN RETROVIRUS LAV [J].
KLATZMANN, D ;
CHAMPAGNE, E ;
CHAMARET, S ;
GRUEST, J ;
GUETARD, D ;
HERCEND, T ;
GLUCKMAN, JC ;
MONTAGNIER, L .
NATURE, 1984, 312 (5996) :767-768